Institutional investors purchased a net $3.4 million shares of MESO during the quarter ended December 2015. This may signal that the smart money is gaining interest in this company as the 4.66% of the shares outstanding that institutional investors hold is among the lowest in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
TIBURON PARTNERS LLP Sold 50.0 Thousand shares of Mesoblast Ltd